CBRS Spectrum Adoption Drives US Manufacturing Innovation Through Private Wireless Networks Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Drive Oil Prices to New Highs Micron Technology Joins 1 Trillion Market Cap Club Amid AIDriven Memory Chip Surge Ebola Risk Elevated to Very High in DR Congo Potential Implications for Regional Economies and Investors Eli Lillys NextGeneration Obesity Drug Retatrutide Clears Key Trial Tesla Stock Consolidates in Tight Range Extends Recovery from Steep Decline AMT Q1 2026 Earnings EPS Surges Past Estimates with 1363 Beat LPL Q1 2026 Earnings Staggering EPS Miss Drives Sharp Stock Decline BTE Q1 2026 Earnings Significant Earnings Miss Highlights Operational Headwinds Tigo Energy Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares American Tower Corporation AMT Q1 2026 Earnings EPS Surges 136 Above Estimates Shares Edge Lower Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat on Strong Operations Stock Holds Steady Lightbridge Corporation LTBR Slips 142 as Stock Tests Key Support Near 1086 Air Lease Corporation Holds Steady at 6500 as Key Support and Resistance Levels Remain in Focus Singularity Future Technology SGLY Edges Higher Small Cap Stock Held in Tight Range Herbalife HLF Surges 2 Breaking Out of Consolidation or Temporary Relief DigitalOcean Holdings DOCN Advances Modestly as Cloud Platform Momentum Persists Kronos Worldwide Inc KRO Q1 2026 Earnings EPS Beats Expectations Amid Challenging Market TD SYNNEX SNX Q1 2026 Earnings Strong EPS Beat of 416 Overshadowed by Tepid Stock Response XPON Q2 2025 Earnings EPS Beats Estimates Despite Revenue Absence AMBP Q1 2026 Earnings Strong EPS Beat of 127 Surprise Amid Stock Decline KGS Q1 2026 Earnings EPS Surprise Drives Optimism Despite Slight Stock Decline UVV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Facility Dogs in Pediatric Care Potential Implications for Healthcare Outcomes and Patient WellBeing Uber Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Declines Valneva VALN Surges 48 as Vaccine Developer Tests Key Resistance